116 related articles for article (PubMed ID: 12079401)
1. Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.
Hartmann A; Mouatt-Prigent A; Vila M; Abbas N; Perier C; Faucheux BA; Vyas S; Hirsch EC
Neurobiol Dis; 2002 Jun; 10(1):28-32. PubMed ID: 12079401
[TBL] [Abstract][Full Text] [Related]
2. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
[TBL] [Abstract][Full Text] [Related]
3. Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note.
Wüllner U; Kornhuber J; Weller M; Schulz JB; Löschmann PA; Riederer P; Klockgether T
Acta Neuropathol; 1999 Apr; 97(4):408-12. PubMed ID: 10208281
[TBL] [Abstract][Full Text] [Related]
4. Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress.
Veech GA; Dennis J; Keeney PM; Fall CP; Swerdlow RH; Parker WD; Bennett JP
J Neurosci Res; 2000 Sep; 61(6):693-700. PubMed ID: 10972966
[TBL] [Abstract][Full Text] [Related]
5. Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL.
Shim JW; Koh HC; Chang MY; Roh E; Choi CY; Oh YJ; Son H; Lee YS; Studer L; Lee SH
J Neurosci; 2004 Jan; 24(4):843-52. PubMed ID: 14749429
[TBL] [Abstract][Full Text] [Related]
6. An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells.
Akao Y; Maruyama W; Yi H; Shamoto-Nagai M; Youdim MB; Naoi M
Neurosci Lett; 2002 Jun; 326(2):105-8. PubMed ID: 12057839
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 and Bax proteins in Lewy bodies from patients with Parkinson's disease and Diffuse Lewy body disease.
Tortosa A; López E; Ferrer I
Neurosci Lett; 1997 Nov; 238(1-2):78-80. PubMed ID: 9464659
[TBL] [Abstract][Full Text] [Related]
8. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.
Yalçınkaya N; Haytural H; Bilgiç B; Özdemir Ö; Hanağası H; Küçükali Cİ; Özbek Z; Akcan U; İdrisoğlu HA; Gürvit H; Tüzün E
Neurosci Lett; 2016 Feb; 615():72-7. PubMed ID: 26806867
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease.
Marshall KA; Daniel SE; Cairns N; Jenner P; Halliwell B
Biochem Biophys Res Commun; 1997 Nov; 240(1):84-7. PubMed ID: 9367887
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Bcl-xL in response to subtoxic beta-amyloid: role in neuronal resistance against apoptotic and oxidative injury.
Luetjens CM; Lankiewicz S; Bui NT; Krohn AJ; Poppe M; Prehn JH
Neuroscience; 2001; 102(1):139-50. PubMed ID: 11226677
[TBL] [Abstract][Full Text] [Related]
11. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease.
Tatton NA
Exp Neurol; 2000 Nov; 166(1):29-43. PubMed ID: 11031081
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in Parkinson's disease: signals for neuronal degradation.
Tatton WG; Chalmers-Redman R; Brown D; Tatton N
Ann Neurol; 2003; 53 Suppl 3():S61-70; discussion S70-2. PubMed ID: 12666099
[TBL] [Abstract][Full Text] [Related]
13. The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo.
Liste I; García-García E; Martínez-Serrano A
J Neurosci; 2004 Dec; 24(48):10786-95. PubMed ID: 15574729
[TBL] [Abstract][Full Text] [Related]
14. Balancing Apoptosis and Autophagy for Parkinson's Disease Therapy: Targeting BCL-2.
Liu J; Liu W; Yang H
ACS Chem Neurosci; 2019 Feb; 10(2):792-802. PubMed ID: 30400738
[TBL] [Abstract][Full Text] [Related]
15. Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer.
Friess H; Lu Z; Andrén-Sandberg A; Berberat P; Zimmermann A; Adler G; Schmid R; Büchler MW
Ann Surg; 1998 Dec; 228(6):780-7. PubMed ID: 9860477
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of lactoferrin on ventral mesencephalon neurons against MPP + is not connected with its iron binding ability.
Wang J; Bi M; Liu H; Song N; Xie J
Sci Rep; 2015 Jun; 5():10729. PubMed ID: 26035688
[TBL] [Abstract][Full Text] [Related]
17. Lack of binding observed between human alpha-synuclein and Bcl-2 protein family.
Nagano Y; Yamashita H; Nakamura T; Takahashi T; Kondo E; Nakamura S
Neurosci Lett; 2001 Dec; 316(2):103-7. PubMed ID: 11742726
[TBL] [Abstract][Full Text] [Related]
18. BCL-xL-dependent light scattering by apoptotic cells.
Boustany NN; Tsai YC; Pfister B; Joiner WM; Oyler GA; Thakor NV
Biophys J; 2004 Dec; 87(6):4163-71. PubMed ID: 15377529
[TBL] [Abstract][Full Text] [Related]
19. Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: a possible anti-tumour mechanism.
Xidakis C; Kolios G; Valatas V; Notas G; Mouzas I; Kouroumalis E
Anticancer Res; 2004; 24(2B):833-41. PubMed ID: 15161035
[TBL] [Abstract][Full Text] [Related]
20. BAX protein-immunoreactivity in midbrain neurons of Parkinson's disease patients.
Horowitz JM; Pastor DM; Goyal A; Kar S; Ramdeen N; Hallas BH; Torres G
Brain Res Bull; 2003 Nov; 62(1):55-61. PubMed ID: 14596892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
